medline.ch Onkologie Urologische Tumoren

	Enhancing urothelial carcinoma diagnosis with artificial intelligence-integrated urine cytology: Biopsy-validated accuracy and efficiency gain. Cancer Cytopathol Lajara S, Cuda J, Geisler DL, Staniszewski C, Yang WL, Atkison K, Lin CY, Shao G, Liu TJ, Crothers B, Dhir R, Khader SN. PMID: 42144873 [PubMed - indexed for MEDLINE]
	Relationship between the status of positive surgical margins and biochemical recurrence: developing a risk stratification model for biochemical recurrence following radical prostatectomy. J Robot Surg Morizane S, Hussein AA, Jing Z, Mahmood AW, Wychowski S, Khan S, Das S, Ahmad A, Iskander J, Harrington G, Khan M, Ahmed Z, Howlader M, Takenaka A, Guru KA. PMID: 42144537 [PubMed - indexed for MEDLINE]
	Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials. Lancet Oncol Siva S, Ali M, Hardcastle N, Kron T, Higgs B, Foroudi F, Ruben J, Appu S, Martin J, Sridharan S, Montgomery R, Davey R, Lin C, Shaw M, Chander S, Sidhom M, Vanneste BGL, Murphy DG, Lawrentschuk N, Pryor D, Wood S, Moon D, Bressel M. PMID: 42144019 [PubMed - as supplied by publisher]
	Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study. Lancet Oncol Siva S, Pryor D, Martin J, Hardcastle N, Moon D, Kron T, Higgs B, Foroudi F, Ruben J, Sridharan S, Montgomery R, Davey R, Lin C, Shaw M, Lawrentschuk N, Appu S, Vanneste BGL, Hofman MS, Murphy DG, De Abreu Lourenco R, Mancuso P, Brook NR, Raman A, Wong LM, Sidhom M, Wood S, Ali M, Bressel M. PMID: 42144018 [PubMed - as supplied by publisher]
	Shared Decision-Making for Prostate Cancer Screening in Racial and Ethnic Minority Populations: A Systematic Review. J Racial Ethn Health Disparities Joung H, Shin H, Jones RA. PMID: 42143174 [PubMed - as supplied by publisher]
	Exploring Lived Experiences of Men Diagnosed With Prostate Cancer in Oman: A Qualitative Study. Health Expect Al-Abri K, Al-Louyahi MH, Al-Samani HS, Al-Ghanboosi MJ, Al-Junaibi KH, Al-Adawi NH, Romadlon DS. PMID: 42142306 [PubMed - indexed for MEDLINE]
	Predicting Positive Surgical Margins in Robot-Assisted Prostatectomy Using Machine Learning Models. Int J Med Robot Fan G, Chen H, Li Y, Chen Y, Tang T. PMID: 42142026 [PubMed - indexed for MEDLINE]
	Impact of Staged Rehabilitation Training on Urinary Incontinence Recovery After Radical Prostatectomy: A Retrospective Analysis. Am J Mens Health Hu Y, Yao L, Liu C, Tian J, Liu A. PMID: 42141375 [PubMed - indexed for MEDLINE]
	Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study. Nat Cancer Jayaram A, Rashid M, Reid AHM, Orlando F, Thakali S, Zakka L, Goncalves M, O'Dwyer J, Alifrangis C, Jones R, Pintus E, Needleman S, Bianchini D, Wingate A, Ng K, Linch M, McGovern U, Staffurth J, Crabb SJ, Brock S, Birtle A, Vainauskas O, Leone G, Chiwewe M, Hackshaw A, Lopes A, Wetterskog D, Demichelis F, Attard G. PMID: 42141175 [PubMed - as supplied by publisher]
	A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer. Invest New Drugs Chandran K, Guo C, Pacey S, Villacampa G, Matthews R, Prout T, Fernandes J, Turner A, Parmar M, Riisnaes R, Ferreira A, Carreira S, Bertan C, Crespo M, Figueiredo I, Yuan W, Bogdan D, Raynaud F, Ruddle R, Calì B, Maddalena M, Calcinotto A, Yap C, Sharp A, Alimonti A, De Bono J, Paschalis A. PMID: 42141162 [PubMed - as supplied by publisher]
	Re: Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-GuÃ©rin (BCG) in BCG-naÃ¯ve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials. Eur Urol Compérat E. PMID: 42140860 [PubMed - as supplied by publisher]
	OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial. Radiother Oncol Corda H, Blanc-Lapierre A, Pigne G, Cartier L, Pasquier D, Ronchin P, Bera G, Hasbini A, Schipman B, Khalifa J, Sargos P, Quivrin M, Schick U, Mallet F, Laude C, Morand C, Loos G, Vaugier L, Mesgouez-Nebout N, Supiot S. PMID: 42140755 [PubMed - as supplied by publisher]
	Circulating microbial metabolites and the gut-prostate axis in prostate cancer: Implications for laboratory biomarkers and therapeutic response. Clin Chim Acta Tan MW, Clister D, Chandra QM, Wangsa CE, Simone CN, Umaya C, Choi J, Park S, Rani A, Akter S, Kim B, Kim SH, de Azambuja Ribeiro RIM, Syahputra RA. PMID: 42140378 [PubMed - as supplied by publisher]
	Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw Flaig TW, Spiess PE, Abern M, An Y, Bangs R, Begovic J, Brown J, Buyyounouski MK, Chan K, Chang P, Chin AI, Guru KA, Herr HW, Hoffman-Censits J, Kaimakliotis H, Kundu S, Lele SM, Luckenbaugh A, Maldonado J, Mei L, Montgomery JS, Parikh M, Patterson A, Peyton C, Plimack ER, Preston MA, Richards K, Seyedin S, Siefker-Radtke AO, Stewart T, Sundi D, Swami U, Tollefson M, Wright JL, Cassara CJ, Sliker B. PMID: 42140269 [PubMed - indexed for MEDLINE]
	Clinical outcomes of deferred cytoreductive nephrectomy after initial systemic therapy in metastatic renal cell carcinoma: A multicenter retrospective study. Urol Oncol Rioja P, Passarella C, Angel M, Valderrama W, Ainaud FB, Anguera G, Gómez V, Ruiz-Granados Á, Plata D, Zapata MI, Orta-Ruiz A, Quiroga MNG, Bourlon MT, Grande E, Ray Manneh Kopp, Molina-Cerrillo J, Maroto P, Sade JP, Castellano D. PMID: 42139851 [PubMed - as supplied by publisher]
	Validation of a large language model as a decision tool for drug interaction in prostate cancer: A comparative study against UpToDate. Meet-URO 5/25 - GENIE study. J Geriatr Oncol Rota S, Tozzi AE, Fanelli M, Dri A, Bortolus G, Tortorella A, Zambotti E, Congi R, Pretto G, Serra R, Membrino A, Di Civita M, Cursano MC, Zanardi E, Procopio G, Santini D, Zucali PA, Verzoni E, Gusmaroli E. PMID: 42139849 [PubMed - as supplied by publisher]
	Feasibility of Establishing Community Living Labs (CoLLabs) to Improve Access to Prostate Health Resources, Education, Amenities, and Community Health: Protocol for a Pragmatic Clinical Trial. JMIR Res Protoc Odedina FT, Bolajoko O, Wimberly Q, Lee D, Willis F, Moutlrie T, Ford W, Green D, Merriweather A, Turner J, Fudge M. PMID: 42139705 [PubMed - indexed for MEDLINE]
	Bladder-preserving trimodality therapy for muscle-invasive bladder cancer: current state-of-the-art. Expert Rev Anticancer Ther Fahey C, Sud S, Remella A, Milowsky M. PMID: 42139181 [PubMed - as supplied by publisher]
	A Rare Case of Primary Pulmonary Choriocarcinoma Metastasizing to the Kidney: Diagnostic and Therapeutic Complexities. Cancer Rep (Hoboken) Belics Z, Fürich A, Bogyó L, Tihanyi H, Madarász M, Rózsa D, Molnár G, Gérecz B, Hupuczi P. PMID: 42138484 [PubMed - indexed for MEDLINE]
	Preliminary results and experiences of fluorescence confocal microscopy using the HistologÂ® Scanner in prostate cancer diagnostics: a feasibility study. BJU Int Meszes-Tóth A, Gyulai AT, Izsák B, Erdélyi AE, Gáti Z, Schönleber J, Tenke P, Köves B. PMID: 42138307 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 178306

Seite 1 von 8916

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung